Clinical trial
A prospective, randomised multi-centre phase II study evaluating the adjuvant, neoadjuvant or palliative treatment with tamoxifen +/- GnRH analogue versus aromatase inhibitor + GnRH analogue in male breast cancer patients.
To determine the estradiol suppression between the three treatment arms after three months.
| Category | Value |
|---|---|
| Study start date | 2012-01-17 |